Levin Capital Strategies, L.P. Purchases 121,549 Shares of Fluidigm Co. (FLDM) Stock

Fluidigm Co. (NASDAQ:FLDM) insider Levin Capital Strategies, L.P. acquired 121,549 shares of the company’s stock in a transaction on Monday, June 18th. The stock was bought at an average price of $4.80 per share, for a total transaction of $583,435.20. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website.

Levin Capital Strategies, L.P. also recently made the following trade(s):

  • On Friday, June 15th, Levin Capital Strategies, L.P. acquired 32,005 shares of Fluidigm stock. The stock was bought at an average price of $4.93 per share, for a total transaction of $157,784.65.
  • On Wednesday, June 13th, Levin Capital Strategies, L.P. acquired 149,715 shares of Fluidigm stock. The stock was bought at an average price of $4.95 per share, for a total transaction of $741,089.25.
  • On Friday, June 8th, Levin Capital Strategies, L.P. acquired 55,763 shares of Fluidigm stock. The stock was bought at an average price of $5.52 per share, for a total transaction of $307,811.76.
  • On Tuesday, May 29th, Levin Capital Strategies, L.P. acquired 1,200 shares of Fluidigm stock. The stock was bought at an average price of $5.60 per share, for a total transaction of $6,720.00.
  • On Friday, May 25th, Levin Capital Strategies, L.P. acquired 9,970 shares of Fluidigm stock. The stock was bought at an average price of $5.69 per share, for a total transaction of $56,729.30.
  • On Tuesday, May 8th, Levin Capital Strategies, L.P. acquired 77,700 shares of Fluidigm stock. The stock was bought at an average price of $5.54 per share, for a total transaction of $430,458.00.
  • On Friday, May 4th, Levin Capital Strategies, L.P. acquired 92,205 shares of Fluidigm stock. The stock was bought at an average price of $5.69 per share, for a total transaction of $524,646.45.
  • On Monday, April 30th, Levin Capital Strategies, L.P. acquired 6,649 shares of Fluidigm stock. The stock was bought at an average price of $5.92 per share, for a total transaction of $39,362.08.
  • On Wednesday, April 25th, Levin Capital Strategies, L.P. acquired 3,700 shares of Fluidigm stock. The stock was bought at an average price of $5.93 per share, for a total transaction of $21,941.00.
  • On Thursday, April 19th, Levin Capital Strategies, L.P. acquired 10,013 shares of Fluidigm stock. The stock was bought at an average price of $5.92 per share, for a total transaction of $59,276.96.

Shares of Fluidigm opened at $5.52 on Thursday, according to MarketBeat. Fluidigm Co. has a 12 month low of $2.52 and a 12 month high of $8.38. The firm has a market cap of $193.02 million, a PE ratio of -4.64 and a beta of 2.99. The company has a current ratio of 2.40, a quick ratio of 1.95 and a debt-to-equity ratio of 3.38.



Fluidigm (NASDAQ:FLDM) last announced its quarterly earnings results on Thursday, May 3rd. The medical research company reported ($0.34) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.41) by $0.07. Fluidigm had a negative net margin of 55.66% and a negative return on equity of 98.85%. The company had revenue of $25.25 million for the quarter, compared to analyst estimates of $25.40 million. equities research analysts forecast that Fluidigm Co. will post -0.9 earnings per share for the current fiscal year.

Several institutional investors and hedge funds have recently made changes to their positions in the company. Levin Capital Strategies L.P. increased its stake in shares of Fluidigm by 6.0% during the 1st quarter. Levin Capital Strategies L.P. now owns 9,715,408 shares of the medical research company’s stock worth $56,738,000 after purchasing an additional 548,338 shares during the last quarter. Millennium Management LLC increased its stake in shares of Fluidigm by 2,126.0% during the 1st quarter. Millennium Management LLC now owns 391,249 shares of the medical research company’s stock worth $2,285,000 after purchasing an additional 373,673 shares during the last quarter. New York State Common Retirement Fund increased its stake in shares of Fluidigm by 47.9% during the 1st quarter. New York State Common Retirement Fund now owns 38,900 shares of the medical research company’s stock worth $227,000 after purchasing an additional 12,600 shares during the last quarter. BlackRock Inc. increased its stake in shares of Fluidigm by 1.3% during the 1st quarter. BlackRock Inc. now owns 2,212,763 shares of the medical research company’s stock worth $12,923,000 after purchasing an additional 27,881 shares during the last quarter. Finally, Engineers Gate Manager LP acquired a new position in shares of Fluidigm during the 1st quarter worth $128,000. Institutional investors own 94.69% of the company’s stock.

FLDM has been the topic of several research reports. BidaskClub lowered shares of Fluidigm from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 24th. Zacks Investment Research upgraded shares of Fluidigm from a “hold” rating to a “buy” rating and set a $6.25 price objective on the stock in a research note on Wednesday, May 16th. Finally, ValuEngine lowered shares of Fluidigm from a “sell” rating to a “strong sell” rating in a research note on Tuesday, May 8th.

Fluidigm Company Profile

Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research in the United States and Europe. It offers analytical systems comprising Helios system, Hyperion imaging system, and Hyperion tissue imager; and assays and reagents, including Maxpar reagents. The company also provides preparatory instruments, such as access array and Juno systems; and analytical instruments comprising Biomark HD system and EP1 system.

Insider Buying and Selling by Quarter for Fluidigm (NASDAQ:FLDM)

Receive News & Ratings for Fluidigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply